Atul Dhir, is the Chief Executive Officer of New Century Health, a national company focused on transforming Oncology and Cardiology care to higher quality, value based care. Dr. Dhir is a physician and scientist with over 25 years of leadership experience in leading innovative healthcare companies in the provider, biotech and Payer services sector.
Before joining New Century Health, Dr. Dhir was the CEO of BiPar Sciences, Inc., a cancer-focused biotech subsidiary of the global Pharmaceutical Company, Sanofi-Aventis. Prior to BiPar Sciences, Dr. Dhir was at US Oncology, (now McKesson Specialty Health), one of the largest providers of outpatient cancer care in the United States. During his years with US Oncology, Dr. Dhir led several businesses, including serving as the President of the company’s Cancer Research Group, one of the nation’s leading cancer clinical trials organization. Dr. Dhir has also held senior positions in the healthcare division of Monsanto Company and as a consultant at McKinsey & Company.
Dr. Dhir received his medical degree from the All India Institute of Medical Sciences in New Delhi, India. He completed his doctorate of philosophy (D.Phil) in medicine from the University of Oxford, UK, where he studied as a Rhodes Scholar.